Drug Filter >
  • Status: IND Filing
  •   > 
Drug Filter
Category:
Chemicals (68) Biologics (36)
Clinical Stage:
Pending (3) Active (76) Discontinued (1)
Bio-Type:
CAR T cell therapy (2) Oncolytic virus (1) Recombinant cytokines (3) Recombinant hormone (2) Bispecific antibody (2) Whole antibody (19) ADC (2) Fusion protein (2)
Company:
Jiangsu Hengrui Medicine (4) Chiatai Tianqing (CTTQ) (3) Genor Biopharma (3) Kelun Pharmaceutical (3) Shanghai Hengrui (3) Alphamab (2) Hangzhou Adamerck Pharmlabs (2) Innovent Biologics (2) Kanion Pharmaceutical (2) Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2) Shanghai Newsummit Biopharma (2) Zhejiang Yongning Pharmaceutical (2) 302 Military Hospital of China (1) Ajanta Pharma (1) Akeso Biopharma (1) Anke Biotechnology (1) BBCA Pharmaceutical (1) Baiyunshan Pharmaceutical (1) Beijing Fengshuo Weikang (1) Beijing ShuangLu Pharmaceutical (1) Bio-Thera Solutions (1) Bossan (1) Buchang Pharma (1) China Pharmaceutical University (1) China State Institute of Pharmaceutical Industry (CSIPI) (1) Chinese PLA General Hospital/Medical School of Chinese PLA (1) Chongqing Fujin Biomedical (1) Chongqing University of Arts and Sciences (1) Cisen Pharmaceutical (1) Dalian Dien Biological Engineering (1) Dongguan Anhao (1) Dongguan Daxin (1) Fochon Pharmaceuticals (1) Foreland Pharma (1) Foshan Ruidiao Pharmaceutical (1) Fosun Pharma (1) Fujian Jinshon Biologicalpharmaceutical (1) GNI Group (1) Generon Corporation (1) Guangzhou Yinnuo Pharmaceutical (1) HEC Pharm (1) Hangzhou Advenchen Laboratories (1) Hangzhou Pharmavaxin (1) Hangzhou Tianlong Pharmaceuticals (1) Hangzhou Zhongmei Huadong Pharmaceutical (1) Hansoh Pharma (1) Hisun Pharm (1) Huabo Biopharm (1) Huadong Medicine (1) ImQuest BioSciences (1) Immune Pharmaceuticals (1) Institute of Materia Medica Chinese Academy of Medical Sciences (1) Institute of Pharmacology & Radiation of AMMS (1) Institute of Pharmacology & Toxicology of AMMS (1) Jianfeng Pharmaceutical (1) Jiangsu Shengdi (1) Jingfeng Pharma (1) Kite Pharma (1) Lee's Pharm (1) Liaoning Haisike pharmaceutical (1) Livzon Group Livzon Pharmaceutical Factory (1) MabSpace Biosciences (1) Merck Serono (1) Nanjing Advenchen Laboratories (1) Nanjing Tech University (1) National Cancer Institute (1) Ningbo Shengjian (1) NuoKang Biopharma (1) Ocean University of China (1) Peking University Health Science Center (1) Penglai Nuokang Pharmaceutical (1) Qilu Pharmaceutical (1) Sanhome Pharmaceutical (1) Sanofi (1) Shandong Provincial Institute of Dermatology and Venereology (1) Shanghai Genomics (1) Shanghai Haihe Pharmaceutical (1) Shanghai Pharma (1) Shanghai Xianfu Chemical Technology (1) Shenyang Pharmaceutical University (1) Sichuan Haisco Pharmaceutical (1) Sichuan Saizhuo Pharmaceutical (1) Sinopharm A-THINK Pharmaceutical (1) Southeast Pharmaceuticals (1) Suzhou Dawnrays Pharmaceutical (1) Suzhou Kanger Biopharmaceutical (1) TOT Biopharm (1) Tasly Pharm (1) Third Military Medical University (1) Tianjin Institute of Pharmaceutical Research (1) Tianjin SinoBiotech (1) WuXi AppTec (1) XuanZhu Pharma (1) Yantai Rongchang Biological Engineering (1) Zhaoke Oncology (1) Zhaoke Pharmaceutical (1) Zhejiang Forever Medicine (1) Zhongsheng Pharmacy (1) 吉林英联尚德科技开发 (1) 浙江浙北药业 (1) 未知 (0)
Indication:
Acne (2) Acute lymphoblastic leukaemia (ALL) (1) Alzheimer's disease (AD) (1) Anemia (1) Arrhythmia (1) Brain ischemia (1) Breast cancer (4) Keratitis (1) Chronic lymphocytic leukemia (CLL) (2) Chronic pain (1) Endometrial cancer (1) Endometriosis (1) Epilepsy/Seizures (1) Erectile dysfunction (ED) (1) Eye disorders (1) Gastric cancer (6) Generalized tonic-clonic status epilepticus (GTCSE) (1) Glioblastoma multiforme (1) Gram-positive and Gram-negative bacterial infections (1) HCV infection (3) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hypercholesterolemia (1) Hyperlipidemia (1) Hypertension (1) Leukemia (1) Lung cancer (3) Melanoma (1) Metastatic colorectal cancer (CRC) (1) Multiple myeloma (MM) (3) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (2) Non small cell lung cancer (NSCLC) (7) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (2) Osteoarthritis (OA) (2) Osteoporosis (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Postmenopausal osteoporosis (1) Psoriasis (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (5) Corneal epithelial defects (1) Solid tumours (14) Stable plaque psoriasis (1) Tuberculosis (1) Type 2 diabetes (7) Venous thromboembolism (VTE) (1) Cardiac ischemic complications (1) Systemic bacterial infections (3) Chronic heart failure (2) Malignant Ascites (1) Age-related macular degeneration (AMD) (2) Pain (1) Anesthesia (1) Macular edema (1) B-cell lymphoma (1) Diabetes (1) Bone metastases from solid tumors (2) HER2-positive metastatic breast cancer (2) Renal carcinoma (1) Hyperphosphatemia (1) Growth failure (1) Gram-positive bacterial infection (1) Gastrointestinal motility disorders (1) Ischemic stroke (1) Gout (1) Thrombosis (1) Alopecia (1) Bacterial infection (1) Urinary tract stones (1) HER2-positive breast cancer (2) Hand-foot-and-mouth disease (HFMD) (1) Temporal epilepsy (1) Tumor imaging agent (1) Liver cancer (1) Liver failure (1) hematological malignancies (1) Immunological disorders (1) Giant cell tumor of bone (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:

CopyRight©2017药渡经纬信息科技(北京)有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码